ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies
February 14, 2022EdiGene, Inc and Neukio Biotherapeutics have announced an R&D collaboration to develop next-generation immune cell therapies, Neukio Biotherapeutics informed via a statement. -
Abcam acquires EdiGene’s Knock-out cell lines and Lysates Portfolio
July 17, 2019Using their proprietary high throughput cell editing platform, EdiGene developed the industry’s largest off-the shelf diploid library of over 2,800 single clonal knockout (KO) cell lines -
EdiGene raises $15 M in Series B funding
April 11, 2019EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for the treatment of genetic ……
Pharma Sources Insight January 2025
